BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6359372)

  • 21. Monoclonal antibody to a human osteogenic sarcoma cell line.
    Lizonová A; Blahová S; Bízik J; Grófová M
    Arch Geschwulstforsch; 1988; 58(3):151-7. PubMed ID: 3046555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoclonal antibodies for radioimmunodetection of tumours and for targeting.
    Baldwin RW; Embleton MJ; Pimm MV
    Bull Cancer; 1983; 70(2):132-6. PubMed ID: 6575842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A unique antigen expressed on myeloid cells and acute leukemia blast cells defined by a monoclonal antibody.
    Ball ED; Graziano RF; Fanger MW
    J Immunol; 1983 Jun; 130(6):2937-41. PubMed ID: 6574189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo localization of anti-osteogenic sarcoma 791T monoclonal antibody in osteogenic sarcoma xenografts.
    Pimm MV; Embleton MJ; Perkins AC; Price MR; Robins RA; Robinson GR; Baldwin RW
    Int J Cancer; 1982 Jul; 30(1):75-85. PubMed ID: 6956558
    [No Abstract]   [Full Text] [Related]  

  • 25. Kinetics of divalent monoclonal antibody binding to tumour cell surface antigens using flow cytometry: standardization and mathematical analysis.
    Roe R; Robins RA; Laxton RR; Baldwin RW
    Mol Immunol; 1985 Jan; 22(1):11-21. PubMed ID: 3856096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sensitivity and selectivity of ricin toxin A chain-monoclonal antibody 791T/36 conjugates against human tumor cell lines.
    Embleton MJ; Byers VS; Lee HM; Scannon P; Blackhall NW; Baldwin RW
    Cancer Res; 1986 Nov; 46(11):5524-8. PubMed ID: 3489523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of a monoclonal antibody recognizing an epitope designated as canine leukocyte-associated antigen.
    Yang WC; Esquenazi V; Carreno M; Vallone T; Fuller L; Roth D; Nery J; Burke G; Miller J
    Transplantation; 1994 Jul; 58(2):233-40. PubMed ID: 7518977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered expression of cell surface membrane antigens in a common acute lymphoblastic leukemia-associated antigen-expressing neuroblastoma cell line (SJ-N-CG) with morphological differentiation.
    Sugimoto T; Sawada T; Negoro S; Kidowaki T; Morioka H; Matsumura T; Kemshead JT; Seeger RC
    Cancer Res; 1985 Jan; 45(1):358-64. PubMed ID: 2981159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line.
    Gougos A; Letarte M
    J Immunol; 1988 Sep; 141(6):1925-33. PubMed ID: 3262644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
    Rapp L; Fuji H
    Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A monoclonal antibody detecting a 39,000 m.w. molecule that is present on B lymphocytes and chronic lymphocytic leukemia cells but is rare on acute lymphocytic leukemia blasts.
    Zipf TF; Lauzon GJ; Longenecker BM
    J Immunol; 1983 Dec; 131(6):3064-72. PubMed ID: 6358359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The mitogenic lectin from Phaseolus vulgaris does not recognize the T3 antigen of human T lymphocytes.
    Kanellopoulos JM; De Petris S; Leca G; Crumpton MJ
    Eur J Immunol; 1985 May; 15(5):479-86. PubMed ID: 3873340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experience in the preparation and experimental use of immunocytostatics.
    Embleton MJ; Pimm MV; Garnett MC; Rowland GF; Simmonds RG; Baldwin RW
    Behring Inst Mitt; 1984 May; (74):108-12. PubMed ID: 6591915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative evaluation of the localization of a monoclonal antibody (791T/36) in human osteogenic sarcoma xenografts.
    Pimm MV; Baldwin RW
    Eur J Cancer Clin Oncol; 1984 Apr; 20(4):515-24. PubMed ID: 6586422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of common acute lymphoblastic leukemia antigen (CALLA) on human malignant melanoma cell lines.
    Carrel S; Schmidt-Kessen A; Mach JP; Heumann D; Girardet C
    J Immunol; 1983 May; 130(5):2456-60. PubMed ID: 6339629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The monoclonal antibodies Trop-4 and 4F2 detect the same membrane antigen that is expressed at an early stage of lymphocyte activation and is retained on secondary lymphocytes.
    Suomalainen HA
    J Immunol; 1986 Jul; 137(2):422-7. PubMed ID: 3487571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective cytotoxicity against human tumour cells by a vindesine-monoclonal antibody conjugate.
    Embleton MJ; Rowland GF; Simmonds RG; Jacobs E; Marsden CH; Baldwin RW
    Br J Cancer; 1983 Jan; 47(1):43-9. PubMed ID: 6571783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of a human sarcoma-associated antigen with monoclonal antibodies.
    Brown JM
    Cancer Res; 1983 May; 43(5):2113-20. PubMed ID: 6299540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct human leukemia-associated cell surface glycoprotein GP160 defined by monoclonal antibody SN6.
    Haruta Y; Seon BK
    Proc Natl Acad Sci U S A; 1986 Oct; 83(20):7898-902. PubMed ID: 3464004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of T44 molecules in an antigen-independent pathway of T cell activation. Analysis of the correlations to the T cell antigen-receptor complex.
    Moretta A; Pantaleo G; Lopez-Botet M; Moretta L
    J Exp Med; 1985 Sep; 162(3):823-38. PubMed ID: 3875683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.